Crossmark

Opportunities and needs in digital phenotyping

Crossref DOI link: https://doi.org/10.1038/s41386-018-0051-7

Published Online: 2018-04-03

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marsch, Lisa A.
License Information

Text and Data Mining valid from 2018-04-03
More Information

Article History

Received: 8 March 2018

Accepted: 11 March 2018

First Online: 3 April 2018

Conflict of interest

: This work was supported by grant P30DA029926 from the National Institute on Drug Abuse, National Institutes of Health (PI: Marsch). In addition to her academic appointment at Dartmouth College, Dr. Marsch is affiliated with several businesses that develop and deploy digital therapeutic interventions. These include HealthSim LLC, Square2 Systems Inc., and Pear Therapeutics Inc. These relationships are extensively managed by Dr. Marsch and her academic institution.